Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells. [electronic resource]
Producer: 20110526Description: 300-9 p. digitalISSN:- 1613-4133
- Antineoplastic Agents -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- BH3 Interacting Domain Death Agonist Protein -- genetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cytochrome P-450 CYP3A
- Cytochrome P-450 CYP3A Inhibitors
- Drug Resistance, Neoplasm -- drug effects
- Drug Synergism
- Estrogen Antagonists -- pharmacology
- Flavanones -- pharmacology
- Gene Silencing
- Humans
- RNA, Small Interfering
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- genetics
- Recombinant Proteins -- pharmacology
- TNF-Related Apoptosis-Inducing Ligand -- pharmacology
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.